Company Profile
Profile: SynFine Research, Inc. provides chemical reference standards and synthesis services to the pharmaceutical & related industries. We also provide services in the development and validation of analytical methodologies, isolation, identification, characterization & structure elucidation of degradation products, impurities & metabolites.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
(+/-)-5-ETHYL-5-PHENYLHYDANTOIN |
2,4-Imidazolidinedione,5-ethyl-5-phenyl-;Hydantoin,5-ethyl-5-phenyl-;5-Ethyl-5-phenyl-2,4-imidazolidinedione;5-Ethyl-5-phenylhydantoin;Nirvanol;5-Phenyl-5-ethylhydantoin;Ethylphenylhydantoin;Desmethylmephenytoin;Normephenytoin;(RS)-5-Ethyl-5-phenyl-2,4-imidazolidinedione;NSC 150466;NSC 33388;2216-93-5 |
631-07-2 | Inquiry | |
(+/-)-IBUPROFEN-D3 |
(+/-)-IBUPROFEN-D3;IBUPROFEN-D3;(+/-)-IBUPROFEN-D3 (ALPHA-METHYL-D3);IBUPROFEN-METHYL-D3;2-(4-Isobutylphenyl)propionic Acid-d3;rac Ibuprofen-d3;α-Methyl-d3-4-(isobutyl)phenylaceticacid;Ibuprofen D3 (Racemic) |
121662-14-4 | Inquiry | |
(1R,2S)-rel-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide hydrochloride |
Cyclopropanecarboxamide,2-(aminomethyl)-N,N-diethyl-1-phenyl-,hydrochloride (1:1),(1R,2S)-rel-;Cyclopropanecarboxamide,2-(aminomethyl)-N,N-diethyl-1-phenyl-,monohydrochloride,cis-(±)-;Cyclopropanecarboxamide,2-(aminomethyl)-N,N-diethyl-1-phenyl-,monohydrochloride,(1R,2S)-rel-;F 2207;Milnacipran hydrochloride;Cyclopropanecarboxamide,2-(aminomethyl)-N,N-diethyl-1-phenyl-,monohydrochloride,cis-;Ixel;Dalcipran;Toledomin;Savella;Tivanyl;Joncia;86181-08-0 |
101152-94-7 | Inquiry | |
(2-(2,6-DICHLOROANILINO)PHENYL) METHANOL |
[2-[(2,6-DICHLOROPHENYL)AMINO]PHENYL]-METHANOL;(2-(2,6-DICHLOROANILINO)PHENYL) METHANOL;DICLOFENAC ALCOHOL;2-[(2,6-Dichlorophenyl)amino]benzenemethanol;o-(2,6-dichloroanilino)benzyl Alcohol;[2-[(2,6-Dichlorophenyl)amino]phenyl]methanol (Diclofenac Impurity);Diclofenac Alcohol (Diclofenac IMpurity);Diclofenac iMpurity C |
27204-57-5 | Inquiry | |
(4,6-DIAMINO-1,3,5-TRIAZINE-2-YL)GUANIDINE |
GuanylMelaMine;MonoguanylMelaMine;GuanylMelaMineHydrochloride;(4,6-DiaMino-s-triazin-2-yl)guanidine;(4,6-diaMino-1,3,5-triazin-2-yl)guanidine;(4,6-DIAMINO-1,3,5-TRIAZINE-2-YL)GUANIDINE;1-(4,6-DiaMino-1,3,5-Triazin-2-Yl)Guanidine;(AMinoiMinoMethyl)-1,3,5-triazine-2,4,6-triaMine;N-(4-aMino-3,6-dihydro-6-iMino-1,3,5-triazin-2-yl)guanidine;Guanidine,N-(4-aMino-3,6-dihydro-6-iMino-1,3,5-triazin-2-yl)- |
4405-08-7 | Inquiry | |
(5ALPHA,17BETA)-N-(2-HYDROXY-1,1-DIMETHYLETHYL)-3-OXO-4-AZAANDROST-1-ENE-17-CARBOXAMIDE |
(5ALPHA,17BETA)-N-(2-HYDROXY-1,1-DIMETHYLETHYL)-3-OXO-4-AZAANDROST-1-ENE-17-CARBOXAMIDE;FINASTERIDE METABOLITE;(5a,17)-N-(2-Hydroxy-1,1-dimethylethyl)-3-oxo- 4-azaandrost-1-ene-17-carboxamide;Finasteride Metabolite: (5alpha,17beta)- N-(2-hydroxy-1,1-diMethylethyl)-3-oxo-4-Azaandrost-1-ene-17-carboxaMide |
116285-36-0 | Inquiry | |
(R)-(+)-WARFARIN |
2H-1-Benzopyran-2-one,4-hydroxy-3-[(1R)-3-oxo-1-phenylbutyl]-;Coumarin,3-(α-acetonylbenzyl)-4-hydroxy-,R-(+)-;2H-1-Benzopyran-2-one,4-hydroxy-3-(3-oxo-1-phenylbutyl)-,(R)-;4-Hydroxy-3-[(1R)-3-oxo-1-phenylbutyl]-2H-1-benzopyran-2-one;(+)-(R)-Warfarin;(+)-Warfarin;R-(+)-Warfarin;(R)-Warfarin;Warfarin,(+)-;Dextrowarfarin;(R)-4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one;2H-1-Benzopyran-2-one 4-hydroxy-3-[(1R)-3-oxo-1-phenylbutyl]- |
5543-58-8 | Inquiry | |
(S)-(-)-WARFARIN |
2H-1-Benzopyran-2-one,4-hydroxy-3-[(1S)-3-oxo-1-phenylbutyl]-;Coumarin,3-(α-acetonylbenzyl)-4-hydroxy-,(S)-(-)-;2H-1-Benzopyran-2-one,4-hydroxy-3-(3-oxo-1-phenylbutyl)-,(S)-;4-Hydroxy-3-[(1S)-3-oxo-1-phenylbutyl]-2H-1-benzopyran-2-one;(-)-Warfarin;(S)-Warfarin;(S)-4-Hydroxy-3-(3-oxo-1-phenylbutyl)-2H-chromen-2-one |
5543-57-7 | Inquiry | |
(S)-Oxybutynin |
Benzeneacetic acid,α-cyclohexyl-α-hydroxy-,4-(diethylamino)-2-butyn-1-yl ester,(αS)-;Benzeneacetic acid,α-cyclohexyl-α-hydroxy-,4-(diethylamino)-2-butynyl ester,(S)-;Benzeneacetic acid,α-cyclohexyl-α-hydroxy-,4-(diethylamino)-2-butynyl ester,(αS)-;(S)-Oxybutynin;Esoxybutynin |
119618-22-3 | Inquiry | |
1,2,3,9-TETRAHYDRO-9-METHTYL-3-METHYLENE-4H-CARBAZOL-4-ONE |
Ondansetron impurity D (PhEur);Ondansetron Related Compound D (USP);9-Methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one;Ondansetron EP Impurity D;1,2,3,9-TETRAHYDRO-9-METHYL-3-METHYLENE-4H-CARBAZOL-4-ONE;1,2,3,9-TETRAHYDRO-9-METHTYL-3-METHYLENE-4H-CARBAZOL-4-ONE;4H-Carbazol-4-one,1,2,3,9-tetrahydro-9-Methyl-3-Methylene-;Ondansetron HCl EP IMpurity-D (USP RC D) |
99614-64-9 | Inquiry | |
1,3,5(10)-ESTRATRIEN-3-OL-17-ONE 3(O->1BETA)-D-GLYCOPYRANOSIDURONIC ACID |
β-D-Glucopyranosiduronic acid,17-oxoestra-1,3,5(10)-trien-3-yl;Glucopyranosiduronic acid,17-oxoestra-1,3,5(10)-trien-3-yl,β-D-;β-D-Glucosiduronic acid,17-oxoestra-1,3,5(10)-trien-3-yl;Estra-1,3,5(10)-trien-17-one,3-(β-D-glucopyranuronosyloxy)-;Estrane,β-D-glucopyranosiduronic acid deriv.;17-Oxoestra-1,3,5(10)-trien-3-yl β-D-glucopyranosiduronic acid;Estrone glucosiduronate;Estrone glucuronide;Estrone monoglucosiduronate;Estrone 3-glucuronide;Estrone monoglucuronide;Estrone β-glucuronide;Estrone β-D-glucuronide;26610-40-2;30137-08-7;125926-19-4;904747-74-6 |
2479-90-5 | Inquiry | |
1-(2-HYDROXYETHYL)-2-HYDROXYMETHYL-5-NITROIMIDAZOLE |
1H-Imidazole-1-ethanol,2-(hydroxymethyl)-5-nitro-;Imidazole-1-ethanol,2-(hydroxymethyl)-5-nitro-;2-(Hydroxymethyl)-5-nitro-1H-imidazole-1-ethanol;1-(2-Hydroxyethyl)-2-(hydroxymethyl)-5-nitroimidazole;Hydroxymetronidazole;2-[2-(Hydroxymethyl)-5-nitro-1H-imidazol-1-yl]ethan-1-ol |
4812-40-2 | Inquiry | |
1-(3-CARBOXYPROPYL)3,7-DIMETHYL XANTHINE |
Cp dmx ii;1-(3-CARBOXYPROPYL)3,7-DIMETHYL XANTHINE;3,6-Dihydro-3,7-diMethyl-2,6-dioxopurine-1(2H)-butyric Acid;2,3,6,7-Tetrahydro-3,7-diMethyl-2,6-dioxo-1H-purine-1-butanoic Acid;4-(3,7-Dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-purin-1-yl)-butryicAcid;1H-Purine-1-butanoic acid, 2,3,6,7-tetrahydro-3,7-dimethyl-2,6-dioxo- |
6493-07-8 | Inquiry | |
1-BENZYL-3-METHOXY-1H-INDAZOLE |
1-Benzyl-3-methoxy-1H-indazole;CHEMBL8099;benzyl 3-methoxy-1h-indazole;SCHEMBL2760339;CTK4I8297;DTXSID10565130;BDBM50406481;ZINC13820690;BENZYL-3-METHOXY-1H-INDAZOLE;1H-Indazole,3-methoxy-1-(phenylmethyl)- |
4454-33-5 | Inquiry | |
1-BENZYL-3-PROPENYLOXY-1H-INDAZOLE |
1-benzyl-3-propenyloxy-1h-indazole;ZINC95934681 |
25854-83-5 | Inquiry | |
1-METHYLBIGUANIDE SULPHATE |
1-Methylbiguanide;UNII-K9BB0L32CH;1-(diaminomethylidene)-2-methylguanidine;Imidodicarbonimidic diamide, N-methyl-;K9BB0L32CH;Biguanide, 1-methyl-;N-Methyl-N"-guanylguanidine;Methylbiguanid;monomethylbiguanide;Metformin hydrochloride impurity E [EP] |
1609-00-3 | Inquiry | |
1-[1-(4-Chlorophenyl)cyclobutyl]-3-methylbutylamine hydrochloride |
Cyclobutanemethanamine,1-(4-chlorophenyl)-α-(2-methylpropyl)-,hydrochloride (1:1);Cyclobutanemethanamine,1-(4-chlorophenyl)-α-(2-methylpropyl)-,hydrochloride;BTS 54-505;1-[1-(4-Chlorophenyl)cyclobutyl]-3-methylbutylamine hydrochloride;[1-[1-(4-Chlorophenyl)cyclobutyl]-3-methylbutan-1-yl]amine hydrochloride;Didemethylsibutramine hydrochloride |
84484-78-6 | Inquiry | |
1A,10B-DIHYDRO-6H-DIBENZO[B,F]OXIRENO[D]AZEPINE-6-CARBOXAMIDE |
6H-Dibenz[b,f]oxireno[d]azepine-6-carboxamide,1a,10b-dihydro-;1a,10b-Dihydro-6H-dibenz[b,f]oxireno[d]azepine-6-carboxamide;Carbamazepine 10,11-epoxide;10,11-Dihydro-5H-dibenz[b,f]azepine-5-carboxamide 10,11-epoxide;10,11-Epoxycarbamazepine;Carbamazepine 10,11-oxide;GP 49-023;10,11-Dihydro-10,11-epoxycarbamazepine;1a,10b-Dihydro-6H-dibenzo[b,f]oxireno[d]azepine-6-carboxamide |
36507-30-9 | Inquiry | |
2',2'-DIFLUORO-2'-DEOXYURIDINE |
2',2'-DIFLUORO-2'-DEOXYURIDINE;2Deoxy-22difluorouridine;2'-Deoxy-2',2'-difluoro-D-uridine;2',2'-Difluorodeoxyuridine;2'-Deoxy-2',2'-difluorouridine ,97%;Uridine,2'-deoxy-2',2'-difluoro-;Gemcitabine impurity C;1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione |
114248-23-6 | Inquiry | |
2,2-DI-N-PROPYLACETAMIDE |
Pentanamide,2-propyl-;Valeramide,2-propyl-;2-Propylpentanamide;Depamide;2-Propylvaleramide;α-Propylvaleramide;2-Propylpentamide;Depamid;Dipropylacetamide;Di-n-propylacetamide;Valpromide |
2430-27-5 | Inquiry |
CONTACT INFORMATION
Sign In for Details